Thursday, June 1, 2023
BestWooCommerceThemeBuilttoBoostSales-728x90

National value-based pricing negotiation for oncology drugs — lessons from China – Nature Reviews Clinical Oncology


  • Barrios, C. et al. Barriers in access to oncology drugs – a global crisis. Nat. Rev. Clin. Oncol. 20, 7–15 (2023).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Cherny, N. I. An appraisal of FDA approvals for adult solid tumours in 2017-2021: has the eagle landed? Nat. Rev. Clin. Oncol. 19, 486–492 (2022).

    Article 
    PubMed 

    Google Scholar
     

  • Neumann, P. J., Cohen, J. T. & Ollendorf, D. A. The Right Price: A Value-Based Prescription for Drug Costs (Oxford Univ. Press, 2021).

  • Cai, L. et al. Impact of the national drug price negotiation policy on the utilization, cost, and accessibility of anticancer medicines in China: a controlled interrupted time series study. J. Glob. Health 12, 11016 (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Li, H. et al. Recent pricing negotiations on innovative medicines pilot in China: experiences, implications, and suggestions. Value Health Reg. Issues 15, 133–137 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • Tang, M., Song, P. & He, J. Progress on drug pricing negotiations in China. Biosci. Trends 13, 464–468 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • Zhang, Y. et al. Prices and clinical benefit of national price-negotiated anticancer medicines in China. PharmacoEconomics 40, 715–724 (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jommi, C., Armeni, P., Costa, F., Bertolani, A. & Otto, M. Implementation of value-based pricing for medicines. Clin. Ther. 42, 15–24 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • Zhang, Y., Wagner, A. K. & Guan, X. Newly approved cancer drugs in China – innovation and clinical benefit. Nat. Rev. Clin. Oncol. 20, 135–136 (2023).

    Article 
    PubMed 

    Google Scholar
     

  • Yuan, J., Lu, Z. K., Xiong, X. & Jiang, B. Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China. BMJ Glob. Health 6, e005519 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     



  • Source link

    Related Articles

    Leave a Reply

    Stay Connected

    9FansLike
    4FollowersFollow
    0SubscribersSubscribe
    - Advertisement -spot_img

    Latest Articles

    %d bloggers like this: